ScholarLens Back to search
2018•PubMedOpen access

Prognostic significance of phosphoinositide 3-kinase p110α and p110β isoforms in non-small cell lung cancer.

Ju Suk Lee, Hyoun Wook Lee, Eun Hee Lee, Moon-Il Park, Jae Seok Lee, Mee-Seon Kim, Seok‐Hyun Kim, Tae Gyu Kim, Hyun‐Yeol Nam, Sang Won Hwang, Jae Hong Park

Open full text 4 citations

Abstract

= 0.005). Our results suggest that p110α and p110β play different roles depending on tumor stage, and that both p110α and p110β have potential as independent prognostic biomarkers of NSCLC.

About this research paper

What this paper is about

= 0.005). Our results suggest that p110α and p110β play different roles depending on tumor stage, and that both p110α and p110β have potential as independent prognostic biomarkers of NSCLC.

Why it matters

OpenAlex reports 4 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

= 0.005). Our results suggest that p110α and p110β play different roles depending on tumor stage, and that both p110α and p110β have potential as independent prognostic biomarkers of NSCLC.

Key concepts: P110α, Immunohistochemistry, Carcinogenesis, Lung cancer, Stage (stratigraphy), Univariate analysis, Phosphoinositide 3-kinase, Cancer

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Prognostic significance of phosphoinositide 3-kinase p110α and p110β isoforms in non-small cell lung cancer. — Research Paper | ScholarLens